HomeCardiovascularPRECISION Trial: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis
PRECISION Trial: Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis
April 1, 2018
This visual abstract represents the important findings of the PRECISION trial. The trial compares the COX-2 selective NSAID celecoxib with traditionally used NSAIDs such as naproxen and ibuprofen. It establishes non inferiority in terms of cardiovascular events and superiority in terms of GI and renal safety. As of March 2017, no guidelines have been published that reflect the results of this trial.